Skip to Main Content

Author Details

David G Huntsman
University of British Columbia
1994
459
115
PMIDPaper TitleJournal TitlePublished Year
37874327Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.Cancer Res2024
37944815Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis.J Obstet Gynaecol Can2024
37874327Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.Cancer Res2024
37944815Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis.J Obstet Gynaecol Can2024
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
37210563Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss.Nat Commun2023
36966138Genomic characterization of DICER1-associated neoplasms uncovers molecular classes.Nat Commun2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
36753816Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.Gynecol Oncol2023
37321155Harmonized molecular classification; assessment of a single-test ProMisE NGS tool.Gynecol Oncol2023
36624343Single-cell transcriptomic analysis of endometriosis.Nat Genet2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
36853783p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk.Mod Pathol2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
37494476Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.Cancer Res2023
37546399Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.Front Oncol2023
37546399Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors' response in non-small cell lung cancer: a multicenter cohort study.Front Oncol2023
37494476Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.Cancer Res2023
37321155Harmonized molecular classification; assessment of a single-test ProMisE NGS tool.Gynecol Oncol2023
36948887p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
37210563Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss.Nat Commun2023
36966138Genomic characterization of DICER1-associated neoplasms uncovers molecular classes.Nat Commun2023
36753816Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.Gynecol Oncol2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
36624343Single-cell transcriptomic analysis of endometriosis.Nat Genet2023
36853783p53-Abnormal "Fields of Dysplasia" in Human Papillomavirus-Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk.Mod Pathol2023
36572991CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.Cancer2023
34543435The utility of color normalization for AI-based diagnosis of hematoxylin and eosin-stained pathology images.J Pathol2022
36101425Epithelial-Mesenchymal Plasticity Induced by Discontinuous Exposure to TGFβ1 Promotes Tumour Growth.Biology (Basel)2022
36100281Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma.Int J Gynecol Cancer2022
36031730The proteome of clear cell ovarian carcinoma.J Pathol2022
36289342Single-cell genomic variation induced by mutational processes in cancer.Nature2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
35640988Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.CMAJ Open2022
35504673Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.Gynecol Oncol2022
35816189Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.Clin Cancer Res2022
35501389BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors.Br J Cancer2022
35877228Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention.Curr Oncol2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
35621648Histologic and Genotypic Characterization of Lung Cancer in the Inuit Population of the Eastern Canadian Arctic.Curr Oncol2022
36065012Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images.Mod Pathol2022
35257510The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignancies.J Pathol Clin Res2022
35246332Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification.Gynecol Oncol2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
34497363Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status.Mod Pathol2022
34543435The utility of color normalization for AI-based diagnosis of hematoxylin and eosin-stained pathology images.J Pathol2022
34697060DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Cancer Epidemiol Biomarkers Prev2022
  • 1 - 50 of 918

Recommended Authors

David N Brown
Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 12
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 20
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 35
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 13
Salvatore Piscuoglio
University of Basel
Career Start Year 2008
Number of shared co-authors 13
Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 2
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 26
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 12
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 54
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 20
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 7
Maryou B Lambros
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 14
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 23
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 12
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 3
Jonathan K Killian
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 18
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 31
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 15
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 10
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 8
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 12
Sang Yong Song
Center for Nanophase Materials Sciences, Oak Ridge National Laboratory
Career Start Year 1995
Number of shared co-authors 2
Rosemary L Balleine
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 106
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 18
Ben Ho Park
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 21
Paul J van Diest
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 20
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 132
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 16
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year 1984
Number of shared co-authors 51
Jeffrey S Ross
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 16

Collaborators

Cyril B Gilks
University of British Columbia
Co-authored papers 186
Janine Senz
University of British Columbia
Co-authored papers 69
Martin K??bel
University of Calgary
Co-authored papers 67
Michael S Anglesio
University of British Columbia
Co-authored papers 60
Samuel Leung
University of British Columbia
Co-authored papers 58
Steve E Kalloger
University of British Columbia
Co-authored papers 44
Stefan Kommoss
Eberhard Karls University Tubingen
Co-authored papers 41
Sohrab P Shah
Memorial Sloan Kettering Cancer Center
Co-authored papers 40
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 40
Aline Talhouk
The University of British Columbia
Co-authored papers 37
Anna DeFazio
Westmead Hospital
Co-authored papers 31
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Co-authored papers 29
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 29
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 28
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 27
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 27
Samuel Aparicio
University of British Columbia
Co-authored papers 27
Marco A Marra
University of British Columbia
Co-authored papers 26
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 26
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 26
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 25
Pardeep Kaurah
University of British Columbia
Co-authored papers 25
Carla Oliveira
Co-authored papers 25
Usha Menon
College of Nursing, University of South Florida
Co-authored papers 24
Amy Lum
University of British Columbia
Co-authored papers 24
Ali Bashashati
University of British Columbia
Co-authored papers 23
Andrew Berchuck
Duke School of Medicine
Co-authored papers 23
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 22
F??tima Carneiro
Centro Hospitalar Universitario de Sao Joao.
Co-authored papers 21
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 21
Release 1.2